The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Nanotechnology-based strategies for treatment of ocular disease
Open accessAbstract
Ocular diseases include various anterior and posterior segment diseases. Due to the unique anatomy and physiology of the eye, efficient ocular drug delivery is a great challenge to researchers and pharmacologists. Although there are conventional noninvasive and invasive treatments, such as eye drops, injections and implants, the current treatments either suffer from low bioavailability or severe adverse ocular effects. Alternatively, the emerging nanoscience and nanotechnology are playing an important role in the development of novel strategies for ocular disease therapy. Various active molecules have been designed to associate with nanocarriers to overcome ocular barriers and intimately interact with specific ocular tissues. In this review, we highlight the recent attempts of nanotechnology-based systems for imaging and treating ocular diseases, such as corneal d iseases, glaucoma, retina diseases, and choroid diseases. Although additional work remains, the progress described herein may pave the way to new, highly effective and important ocular nanomedicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global estimates of visual impairment: 2010
Pascolini, D., & Mariotti, S. P. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300539 · Cited by 3,763
The Impact of Nanoscience on Heterogeneous Catalysis
Bell, A. T. (2003) · Science · doi:10.1126/science.1083671 · Cited by 2,510
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
Preservatives in eyedrops: The good, the bad and the ugly
Baudouin, C., Labbé, A., Liang, H., Pauly, A., & Brignole-Baudouin, F. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.001 · Cited by 1,084
The physics, biophysics and technology of photodynamic therapy
Wilson, B. C., & Patterson, M. S. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/9/r01 · Cited by 1,006
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Nanoscience, Nanotechnology, and Chemistry
Whitesides, G. M. (2005) · Small · doi:10.1002/smll.200400130 · Cited by 719
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Cunha-Vaz, J. (1979) · Survey of Ophthalmology · doi:10.1016/0039-6257(79)90158-9 · Cited by 423
The bisretinoids of retinal pigment epithelium
Sparrow, J. R., Gregory-Roberts, E., Yamamoto, K., Blonska, A., Ghosh, S. K., Ueda, K., & Zhou, J. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.12.001 · Cited by 392
Applications of nanoparticles in ophthalmology
Diebold, Y., & Calonge, M. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.002 · Cited by 392
(2000) · PubMed · Cited by 358
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Ghate, D., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 329
Role of Mucins in the Function of the Corneal and Conjunctival Epithelia
Gipson, I. K., & Argüeso, P. (2003) · International Review of Cytology · doi:10.1016/s0074-7696(03)31001-0 · Cited by 322
Ocular novel drug delivery: impacts of membranes and barriers
Barar, J., Javadzadeh, A. R., & Omidi, Y. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.567 · Cited by 308
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 285
Nanoscience: Friction and Rheology on the Nanometer Scale
Meyer, E., Gyalog, T., Overney, R. M., & Dransfeld, K. (1998) · WORLD SCIENTIFIC eBooks · doi:10.1142/3026 · Cited by 272
Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles
Anderson, S. A., Rader, R. K., Westlin, W. F., Null, C., Jackson, D., Lanza, G. M., Wickline, S. A., & Kotyk, J. J. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200009)44:3<433::aid-mrm14>3.0.co;2-9 · Cited by 271
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Patterns of adherence to diabetes vision care guidelines
Schoenfeld, E. R., Greene, J. M., Wu, S. Y., & Leske, M. C. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00600-x · Cited by 253
Retinal pigment epithelium development, plasticity, and tissue homeostasis
Fuhrmann, S., Zou, C., & Levine, E. M. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2013.09.003 · Cited by 243
Gold nanocages as contrast agents for spectroscopic optical coherence tomography
Cang, H., Sun, T., Li, Z.-Y., Chen, J., Wiley, B. J., Xia, Y., & Li, X. (2005) · Optics Letters · doi:10.1364/ol.30.003048 · Cited by 234
Nanomedicines for ocular NSAIDs: safety on drug delivery
Araújo, J., Gonzalez, E., Egea, M. A., Garcia, M. L., & Souto, E. B. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.003 · Cited by 223
The mechanical properties of the rabbit and human cornea
Jue, B., & Maurice, D. M. (1986) · Journal of Biomechanics · doi:10.1016/0021-9290(86)90135-1 · Cited by 222
Amrite, A. C., & Kompella, U. B. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.12.0005 · Cited by 212
Ideta, R., Tasaka, F., Jang, W.-D., Nishiyama, N., Zhang, G.-D., Harada, A., Yanagi, Y., Tamaki, Y., Aida, T., & Kataoka, K. (2005) · Nano Letters · doi:10.1021/nl051679d · Cited by 196
Corneal epithelial tight junctions and their response to lipopolysaccharide challenge.
Yi, X., Wang, Y., & Yu, F. S. (2000) · PubMed · Cited by 188
The blood-ocular barriers: past, present, and future
Cunha-vaz, J. G. (1997) · Documenta Ophthalmologica · doi:10.1007/bf02569055 · Cited by 187
Nanomaterials for Ocular Drug Delivery
Liu, S., Jones, L., & Gu, F. X. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201100419 · Cited by 185
Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy
Yuan, X., Marcano, D. C., Shin, C. S., Hua, X., Isenhart, L. C., Pflugfelder, S. C., & Acharya, G. (2015) · ACS Nano · doi:10.1021/nn506599f · Cited by 177
Quantum dots in bio-imaging: Revolution by the small
Arya, H., Kaul, Z., Wadhwa, R., Taira, K., Hirano, T., & Kaul, S. C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.043 · Cited by 158
Martens, T., Remaut, K., Deschout, H. G., Engbersen, J. F. J., Hennink, W. E., van Steenbergen, M. J., Demeester, J., Smedt, S. C. D., & Braeckmans, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.030 · Cited by 157
Mun, E. A., Morrison, P. W. J., Williams, A. C., & Khutoryanskiy, V. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500332m · Cited by 154
The Topography of Normal Corneas
Dingeldein, S. A. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010526024 · Cited by 149
Weijtens, O., Schoemaker, R. C., Romijn, F. P. H. T. M., Cohen, A. F., Lentjes, E. G. W. M., & van Meurs, J. C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01176-4 · Cited by 148
Flurbiprofen Loaded Biodegradable Nanoparticles for Ophtalmic Administration
Vega, E., Egea, M. A., Valls, O., Espina, M., & García, M. L. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20685 · Cited by 137
Zhang, J., & Wang, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.001 · Cited by 131
Fabrication of a Micellar Supramolecular Hydrogel for Ocular Drug Delivery
Zhang, Z., He, Z., Liang, R., Ma, Y., Huang, W., Jiang, R., Shi, S., Chen, H., & Li, X. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01526 · Cited by 129
Sustained Drug Release in Nanomedicine: A Long-Acting Nanocarrier-Based Formulation for Glaucoma
Natarajan, J. V., Darwitan, A., Barathi, V. A., Ang, M., Htoon, H. M., Boey, F., Tam, K. C., Wong, T. T. L., & Venkatraman, S. S. (2014) · ACS Nano · doi:10.1021/nn4046024 · Cited by 128
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Rajala, A., Wang, Y., Zhu, Y., Ranjo‐Bishop, M., Ma, J., Mao, C., & Rajala, R. V. S. (2014) · Nano Letters · doi:10.1021/nl502275s · Cited by 121
Nanomedicine Approaches for Corneal Diseases
Chaurasia, S. S., Lim, R. R., Lakshminarayanan, R., & Mohan, R. R. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6020277 · Cited by 117
Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems
Occhiutto, M. L., Freitas, F. R., Maranhão, R. C., & Costa, V. P. (2012) · Pharmaceutics · doi:10.3390/pharmaceutics4020252 · Cited by 112
Light-Activated, In Situ Forming Gel for Sustained Suprachoroidal Delivery of Bevacizumab
Tyagi, P., Barros, M. D., Stansbury, J. W., & Kompella, U. B. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300716t · Cited by 105
Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina
del Pozo‐Rodríguez, A., Delgado, D., Rodríguez‐Gascón, A., & Solinís, M. Á. (2013) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2012.0128 · Cited by 101
Shi, S., Zhang, Z., Luo, Z., Yu, J., Liang, R., Li, X., & Chen, H. (2015) · Scientific Reports · doi:10.1038/srep11337 · Cited by 101
Nanotechnology in ophthalmology
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2010) · Canadian Journal of Ophthalmology · doi:10.3129/i10-090 · Cited by 98
Vega, E., Egea, Calpena, A. C., Espina, M., & García (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28481 · Cited by 98
Pan, Q., Xu, Q., Boylan, N. J., Lamb, N. W., Emmert, D. G., Yang, J., Tang, L. J., Heflin, T., Alwadani, S., Eberhart, C. G., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.009 · Cited by 96
Effect of Eye Pigmentation on Transscleral Drug Delivery
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0214 · Cited by 95
Chen, C., Lu, D., Yeh, Y., Shiau, & Chiang (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24447 · Cited by 95
Kinetics of macromolecules injected into the subretinal space
Marmor, M. F., Negi, A., & Maurice, D. M. (1985) · Experimental Eye Research · doi:10.1016/0014-4835(85)90138-1 · Cited by 91
ElShaer, A., Mustafa, S. M., Kasar, M., et al. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020014 · Cited by 83
Mastorakos, P., Kambhampati, S. P., Mishra, M. K., Wu, T., Song, E., Hanes, J. S., & Kannan, R. M. (2014) · Nanoscale · doi:10.1039/c4nr04284k · Cited by 76
Parveen, S., & Sahoo, S. K. (2010) · Cancer Nanotechnology · doi:10.1007/s12645-010-0006-0 · Cited by 74
Chou, T. Y., & Hong, B. Y. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s58242 · Cited by 72
Cationic core–shell liponanoparticles for ocular gene delivery
Jiang, M., Gan, L., Zhu, C., Dong, Y., Liu, J., & Gan, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.079 · Cited by 70
Self-citationHosoya, H., Dobroff, A. S., Driessen, W. H. P., Vittorio Cristini, C., Brinker, L. M., Staquicini, F. I., Cardó‐Vila, M., D’Angelo, S., Ferrara, F., Proneth, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525796113 · Cited by 67
Read, S. P., Cashman, S. M., & Kumar‐Singh, R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.167 · Cited by 63
Quantum dots trace lymphatic drainage from the mouse eye
Tam, A. L. C., Gupta, N., Zhang, Z., & Yücel, Y. H. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/42/425101 · Cited by 58
Karla, P. K., Earla, R., Boddu, S. H., Johnston, T. P., Pal, D., & Mitra, A. K. (2009) · Current Eye Research · doi:10.1080/02713680802518251 · Cited by 58
Functional neuroanatomy of visual object naming: a PET study
Kiyosawa, M., Inoue, C., Kawasaki, T., Tokoro, T., Ishii, K., Ohyama, M., Senda, M., & Soma, Y. (1996) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00695250 · Cited by 57
The Noncorneal Route in Ocular Drug Delivery
Ahmed, I. (2003) · CRC Press eBooks · doi:10.1201/9780203912072-15 · Cited by 57
Lu, D., Shiau, C.-Y., Chiang, C., Chen, & Yeh, M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s39622 · Cited by 55
Katragadda, S., Talluri, R. S., & Mitra, A. K. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.110 · Cited by 54
Chew, E. Y., Glassman, A. R., Beck, R. W., Bressler, N. M., Fish, G. E., Ferris, F. L., & Kinyoun, J. L. (2010) · Retina · doi:10.1097/iae.0b013e3181f049a8 · Cited by 44
Mitra, M., Kandalam, M., Rangasamy, J., Shankar, B., Maheswari, U. K., Swaminathan, S., & Krishnakumar, S. (2013) · Europe PMC (PubMed Central) · Cited by 44
When nanotechnology meets the ocular surface
Bucolo, C., Maltese, A., & Drago, F. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.3.325 · Cited by 42
Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells
Kansara, V. S., Paturi, D., Luo, S., Gaudana, R., & Mitra, A. K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.008 · Cited by 30
Jwala, J., Vadlapatla, R. K., Vadlapudi, A. D., Boddu, S. H. S., Pal, D., & Mitra, A. K. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0155 · Cited by 26
Wang, Z.-J., Chauvin, B., Maillard, P., Hammerer, F., Carez, D., Croisy, A., Sandré, C., Chollet‐Martin, S., Prognon, P., Paul, J., et al. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.06.005 · Cited by 24
Impacts of Nanomedicines in Ocular Pharmacotherapy
Nakhlband, A., & Barar, J. (2011) · Europe PMC (PubMed Central) · doi:10.5681/bi.2011.003 · Cited by 21
A New Vision for the Eye: Unmet Ocular Drug Delivery Needs
Rivers, H. M., Chaudhuri, S. R., Shah, J. C., & Mittal, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1717-z · Cited by 18
Al‐Hussaini, H., Kilarkaje, N., Shahabi, G., & Al‐Mulla, F. (2016) · Medical Principles and Practice · doi:10.1159/000446480 · Cited by 14
Ophthalmic Applications of Nanotechnology
Raghava, S., Goel, G., & Kompella, U. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-375-2_22 · Cited by 11
Cited by
Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview
Burdușel, A.-C., Gherasim, O., Grumezescu, A. M., Mogoantă, L., Ficai, A., & Andronescu, E. (2018) · Nanomaterials · doi:10.3390/nano8090681 · Cited by 1,343
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Xia, Q., Zhang, Y., Li, Z., Hou, X., & Feng, N. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.01.011 · Cited by 665
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Metadata
- Authors
- Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 7
- Issue
- 3
- Pages
- 281-291
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2550936658
- Cited by
- 375
- References
- 77
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.